These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23602875)

  • 1. Molecular basis of cross-species reactivities of human versus porcine CTLA-4.
    Peraino JS; Zhang H; Li G; Huang CA; Wang Z
    Hum Immunol; 2013 Jul; 74(7):842-8. PubMed ID: 23602875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
    Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A
    J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A truncated diphtheria toxin based recombinant porcine CTLA-4 fusion toxin.
    Peraino JS; Schenk M; Zhang H; Li G; Hermanrud CE; Neville DM; Sachs DH; Huang CA; Duran-Struuck R; Wang Z
    J Immunol Methods; 2013 May; 391(1-2):103-11. PubMed ID: 23470981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of soluble porcine CTLA-4 in yeast Pichia pastoris.
    Peraino J; Zhang H; Hermanrud CE; Li G; Sachs DH; Huang CA; Wang Z
    Protein Expr Purif; 2012 Apr; 82(2):270-8. PubMed ID: 22326797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine CD80: cloning, characterization, and evidence for its role in direct human T-cell activation.
    Tadaki DK; Williams A; Lee KP; Kirk AD; Harlan DM
    Xenotransplantation; 2003 May; 10(3):252-8. PubMed ID: 12694545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
    Morton PA; Fu XT; Stewart JA; Giacoletto KS; White SL; Leysath CE; Evans RJ; Shieh JJ; Karr RW
    J Immunol; 1996 Feb; 156(3):1047-54. PubMed ID: 8557978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
    Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R
    Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.
    Peach RJ; Bajorath J; Naemura J; Leytze G; Greene J; Aruffo A; Linsley PS
    J Biol Chem; 1995 Sep; 270(36):21181-7. PubMed ID: 7545666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties.
    Vasu C; Wang A; Gorla SR; Kaithamana S; Prabhakar BS; Holterman MJ
    Int Immunol; 2003 Feb; 15(2):167-75. PubMed ID: 12578846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.
    Rivard CJ; Tanabe T; Lanaspa MA; Watanabe H; Nomura S; Andres-Hernando A; Garth K; Sekijima M; Ishimoto T; Ariyoshi Y; Garcia GE; Shah J; Lennan B; Tasaki M; Pomposelli T; Shimizu A; Sachs DH; Johnson RJ; Yamada K
    Transpl Int; 2018 Oct; 31(10):1164-1177. PubMed ID: 29722117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
    J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
    Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
    Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity and cross-reactivity engineering of CTLA4-Ig to modulate T cell costimulation.
    Xu Z; Juan V; Ivanov A; Ma Z; Polakoff D; Powers DB; Dubridge RB; Wilson K; Akamatsu Y
    J Immunol; 2012 Nov; 189(9):4470-7. PubMed ID: 23018459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative immunomodulatory strategies for xenotransplantation: CD80/CD86-CTLA4 pathway-modified immature dendritic cells promote xenograft survival.
    Tian M; Lv Y; Zhai C; Zhu H; Yu L; Wang B
    PLoS One; 2013; 8(7):e69640. PubMed ID: 23922766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer.
    Bengsch F; Knoblock DM; Liu A; McAllister F; Beatty GL
    Cancer Immunol Immunother; 2017 Dec; 66(12):1609-1617. PubMed ID: 28856392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity.
    Tadaki DK; Craighead N; Saini A; Celniker A; Burkly LC; Lee KP; Chute JP; Harlan DM; Kirk AD
    Transplantation; 2000 Jul; 70(1):162-7. PubMed ID: 10919595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics.
    van der Merwe PA; Bodian DL; Daenke S; Linsley P; Davis SJ
    J Exp Med; 1997 Feb; 185(3):393-403. PubMed ID: 9053440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
    Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
    J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of small molecular CTLA4 analogs with CD80-binding affinity.
    Liu F; Su L; Chen Z; Feng D; Wei J; Sun J
    Biochem Biophys Res Commun; 2019 Jun; 513(3):694-700. PubMed ID: 30987824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
    Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.